Differentiation into Macrophages
CHAPTER 12 Leukocyte Development, Kinetics, and Functions 165 REFERENCES
1. von Vietinghoff, S., & Ley, K. (2008) Homeostatic regulation of blood neutrophil counts. J Immunol, 181(8), 5183–5188. 2. Price, T. H., Chatta, G. S., & Dale, D. C. (1996). Effect of re-
combinant granulocyte colony-stimulating factor on neutro- phil kinetics in normal young and elderly humans. Blood,
88(1), 335–340.
3. Chaiworapongsa, T., Romero, R., Berry, S. M., et al. (2011). The role of granulocyte colony-stimulating factor in the neutro- philia observed in the fetal inflammatory response syndrome.
J Perinat Med, 39(6), 653–666.
4. Summers, C., Rankin, S. M., Condliffe, A. M., et al. (2010). Neutrophil kinetics in health and disease. Trends Immunol,
31(8), 318–324.
5. Iwasaki, H., & Akashi, K. (2007). Hematopoietic developmen- tal pathways: on cellular basis. Oncogene, 26(47), 6687–6696. 6. Terstappen, L. W., Huang, S., Safford, M., et al. (1991). Sequen- tial generations of hematopoietic colonies derived from single nonlineage-committed CD341CD38– progenitor cells. Blood,
77(6), 1218–1227.
7. Manz, M. G., Miyamoto, T., Akashi, K., & Weissman, I. L. (2002). Prospective isolation of human clonogenic common myeloid progenitors. Proc Natl Acad Sci U S A, 99(18), 11872– 11877.
8. Adams, G. B., & Scadden, D. T. (2006). The hematopoietic stem cell in its place. Nat Immunol, 7(4), 333–337.
9. Mufti, G. J., Bennett, J. M., Goasguen, J., et al. (2008). Diagno- sis and classification of myelodysplastic syndrome: Interna- tional Working Group on Morphology of Myelodysplastic Syndrome (IWGM-MDS) consensus proposals for the defini- tion and enumeration of myeloblasts and ring sideroblasts.
Haematologica, 93(11), 1712–1717.
10. Faurschou, M., & Borregaard, N. (2003). Neutrophil granules and secretory vesicles in inflammation. Microbes Infect, 5(14), 1317–1327.
11. Cornbleet, P. J. (2002). Clinical utility of the band count. Clin
Lab Med, 22(1), 101–136.
12. Reference leukocyte (WBC) differential count (proportional) and
evaluation of instrumental methods; approved standard-Second Edition. (H20-A2). Vol 27(4): Clinical and Laboratory Stan-
dards Institute (CLSI); 2007.
13. Dancey, J. T., Deubelbeiss, K. A., Harker, L. A., & Finch, C. A. (1976). Neutrophil kinetics in man. J Clin Invest, 58(3), 705–715. 14. Athens, J. W., Haab, O. P., Raab, S. O., et al. (1961). Leukoki- netic studies. IV. The total blood, circulating and marginal granulocyte pools and the granulocyte turnover rate in normal subjects. J Clin Invest, 40, 989–995.
15. Hetherington, S. V., & Quie, P. G. (1985). Human polymorpho- nuclear leukocytes of the bone marrow, circulation, and margin- ated pool: function and granule protein content. Am J Hematol,
20(3), 235–246.
16. Cartwright, G. E., Athens, J. W., & Wintrobe, M. M. (1964). The kinetics of granulopoiesis in normal man. Blood, 24, 780–803. 17. Cowburn, A. S., Condliffe, A. M., Farahi, N., et al. (2008).
Advances in neutrophil biology: clinical implications. Chest,
134(3), 606–612.
18. Saverymuttu, S. H., Peters, A. M., Keshavarzian, A., et al. (1985). The kinetics of 111indium distribution following in- jection of 111indium labelled autologous granulocytes in man.
Br J Haematol, 61(4), 675–685.
19. Zarbock, A., Ley, K., McEver, R. P., & Hidalgo, A. (2011). Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow. Blood, 118(26), 6743–6751.
20. Ley, K., Laudanna, C., Cybulsky, M. I., & Nourshargh, S. (2007). Getting to the site of inflammation: the leukocyte ad- hesion cascade updated. Nat Rev Immunol, 7(9), 678–689.
21. Mayadas, T. N., & Cullere, X. (2005). Neutrophil beta2 integrins: moderators of life or death decisions. Trends Immunol,
26(7), 388–395.
22. Burg, N. D., & Pillinger, M. H. (2001). The neutrophil: func- tion and regulation in innate and humoral immunity. Clin
Immunol, 99(1), 7–17.
23. Stuart, L. M., & Ezekowitz, R. A. (2005). Phagocytosis: elegant complexity. Immunity, 22(5), 539–550.
24. Dale, D. C., Boxer, L., & Liles, W. C. (2008). The phagocytes: neutrophils and monocytes. Blood, 112(4), 935–945.
25. Brinkmann, V., & Zychlinsky, A. (2007). Beneficial suicide: why neutrophils die to make NETs. Nat Rev Microbiol, 5(8), 577–582.
26. Brinkmann, V., & Zychlinsky, A. (2012). Neutrophil extracel- lular traps: is immunity the second function of chromatin?
J Cell Biol, 198(5), 773–783.
27. Mori, Y., Iwasaki, H., Kohno, K., et al. (2009). Identification of the human eosinophil lineage-committed progenitor: revision of phenotypic definition of the human common myeloid pro- genitor. J Exp Med, 206(1), 183–193.
28. Uhm, T. G., Kim, B. S., & Chung, I. Y. (2012). Eosinophil de- velopment, regulation of eosinophil-specific genes, and role of eosinophils in the pathogenesis of asthma. Allergy Asthma
Immunol Res, 4(2), 68–79.
29. Takatsu, K., & Nakajima, H. (2008). IL-5 and eosinophilia.
Curr Opin Immunol, 20(3), 288–294.
30. Melo, R. C., Spencer, L. A., Perez, S. A., et al. (2009). Vesicle- mediated secretion of human eosinophil granule-derived major basic protein. Lab Invest, 89(7), 769–781.
31. Giembycz, M. A., & Lindsay, M. A. (1999). Pharmacology of the eosinophil. Pharmacol Rev, 51(2), 213–340.
32. Steinbach, K. H., Schick, P., Trepel, F., et al. (1979). Estimation of kinetic parameters of neutrophilic, eosinophilic, and baso- philic granulocytes in human blood. Blut, 39(1), 27–38. 33. Park, Y. M., & Bochner, B. S. (2010). Eosinophil survival and
apoptosis in health and disease. Allergy Asthma Immunol Res,
2(2), 87–101.
34. Throsby, M., Herbelin, A., Pleau, J. M., & Dardenne, M. (2000). CD11c1 eosinophils in the murine thymus: develop- mental regulation and recruitment upon MHC class I-restricted thymocyte deletion. J Immunol, 165(4), 1965–1975.
35. Hogan, S. P., Rosenberg, H. F., Moqbel, R., et al. (2008). Eosinophils: biological properties and role in health and disease. Clin Exp Allergy, 38(5), 709–750.
36. Spencer, L. A., Szela, C. T., Perez, S. A., et al. (2009). Human eosinophils constitutively express multiple Th1, Th2, and im- munoregulatory cytokines that are secreted rapidly and differentially. J Leukoc Biol, 85(1), 117–123.
37. Hagan, P., Wilkins, H. A., Blumenthal, U. J., Hayes, R. J., & Greenwood, B. M. (1985). Eosinophilia and resistance to
Schistosoma haematobium in man. Parasite Immunol, 7(6),
625–632.
38. Phipps, S., Benyahia, F., Ou, T. T., et al. (2004). Acute allergen-induced airway remodeling in atopic asthma. Am J
Respir Cell Mol Biol, 31(6), 626–632.
39. Robinson, D. S. (2013). Mepolizumab for severe eosinophilic asthma. Expert Rev Respir Med, 7(1), 13–17.
40. Walsh, R. E., & Gaginella, T. S. (1991). The eosinophil in inflammatory bowel disease. Scand J Gastroenterol, 26(12), 1217–1224.
41. Hogan, S. P., Waddell, A., & Fulkerson, P. C. (2013). Eosinophils in infection and intestinal immunity. Curr Opin
Gastroenterol, 29(1), 7–14.
42. Min, B., Brown, M. A., & Legros, G. (2012). Understanding the roles of basophils: breaking dawn. Immunology, 135(3), 192–197.
166
PART II Blood Cell Production, Structure, and Function43. Ohmori, K., Luo, Y., Jia, Y., et al. (2009). IL-3 induces basophil expansion in vivo by directing granulocyte-monocyte progenitors to differentiate into basophil lineage-restricted progenitors in the bone marrow and by increasing the number of basophil/mast cell progenitors in the spleen. J Immunol, 182(5), 2835–2841. 44. Ohnmacht, C., & Voehringer, D. (2009). Basophil effector
function and homeostasis during helminth infection. Blood,
113(12), 2816–2825.
45. Didichenko, S. A., Spiegl, N., Brunner, T., & Dahinden, C. A. (2008). IL-3 induces a Pim1-dependent antiapoptotic pathway in primary human basophils. Blood, 112(10), 3949–3958. 46. Wada, T., Ishiwata, K., Koseki, H., et al. (2010). Selective ablation
of basophils in mice reveals their nonredundant role in acquired immunity against ticks. J Clin Invest, 120(8), 2867–2875. 47. Obata, K., Mukai, K., Tsujimura, Y., et al. (2007). Basophils are
essential initiators of a novel type of chronic allergic inflam- mation. Blood, 110(3), 913–920.
48. Sullivan, B. M., & Locksley, R. M. (2009). Basophils: a nonre- dundant contributor to host immunity. Immunity, 30(1), 12–20. 49. Schroeder, J. T., MacGlashan, D. W., Jr., & Lichtenstein, L. M.
(2001). Human basophils: mediator release and cytokine pro- duction. Adv Immunol, 77, 93–122.
50. Gauchat, J. F., Henchoz, S., Mazzei, G., et al. (1993). Induction of human IgE synthesis in B cells by mast cells and basophils.
Nature, 365(6444), 340–343.
51. Falcone, F. H., Zillikens, D., & Gibbs, B. F. (2006). The 21st century renaissance of the basophil? Current insights into its role in allergic responses and innate immunity. Exp Dermatol,
15(11), 855–864.
52. Tschopp, C. M., Spiegl, N., Didichenko, S., et al. (2006). Gran- zyme B, a novel mediator of allergic inflammation: its induction and release in blood basophils and human asthma. Blood,
108(7), 2290–2299.
53. Spiegl, N., Didichenko, S., McCaffery, P., et al. (2008). Human basophils activated by mast cell-derived IL-3 express retinalde- hyde dehydrogenase-II and produce the immunoregulatory mediator retinoic acid. Blood, 112(9), 3762–3771.
54. de Paulis, A., Prevete, N., Fiorentino, I., et al. (2006). Expres- sion and functions of the vascular endothelial growth factors and their receptors in human basophils. J Immunol, 177(10), 7322–7331.
55. Hallgren, J., & Gurish, M. F. (2011). Mast cell progenitor traf- ficking and maturation. Adv Exp Med Biol, 716, 14–28. 56. Valent, P. (1994). The phenotype of human eosinophils, basophils,
and mast cells. J Allergy Clin Immunol, 94(6 Pt 2), 1177–1183. 57. Valent, P., Spanblochl, E., Sperr, W. R., et al. (1992). Induction
of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture. Blood, 80(9), 2237–2245.
58. Kambe, N., Hiramatsu, H., Shimonaka, M., et al. (2004). Devel- opment of both human connective tissue-type and mucosal-type mast cells in mice from hematopoietic stem cells with identical distribution pattern to human body. Blood, 103(3), 860–867. 59. Nakano, N., Nishiyama, C., Yagita, H., et al. (2009). Notch
signaling confers antigen-presenting cell functions on mast cells. J Allergy Clin Immunol, 123(1), 74–81, e71.
60. Heib, V., Becker, M., Taube, C., & Stassen, M. (2008). Advances in the understanding of mast cell function. Br J Hae-
matol, 142(5), 683–694.
61. Galli, S. J., Grimbaldeston, M., & Tsai, M. (2008). Immuno- modulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol, 8(6), 478–486.
62. Nichols, B. A., Bainton, D. F., & Farquhar, M. G. (1971). Dif- ferentiation of monocytes. Origin, nature, and fate of their azurophil granules. J Cell Biol, 50(2), 498–515.
63. Ziegler-Heitbrock, L., Ancuta, P., Crowe, S., et al. (2010). No- menclature of monocytes and dendritic cells in blood. Blood,
116(16), e74–80.
64. Meuret, G., Bammert, J., & Hoffmann, G. (1974). Kinetics of human monocytopoiesis. Blood, 44(6), 801–816.
65. Swirski, F. K., Nahrendorf, M., Etzrodt, M., et al. (2009). Iden- tification of splenic reservoir monocytes and their deployment to inflammatory sites. Science, 325(5940), 612–616.
66. Meuret, G., Batara, E., & Furste, H. O. (1975). Monocytopoi- esis in normal man: pool size, proliferation activity and DNA synthesis time of promonocytes. Acta Haematol, 54(5), 261–270.
67. Whitelaw, D. M. (1972). Observations on human monocyte kinetics after pulse labeling. Cell Tissue Kinet, 5(4), 311–317.
68. Kumar, S., & Jack, R. (2006). Origin of monocytes and their differentiation to macrophages and dendritic cells. J Endotoxin
Res, 12(5), 278–284.
69. Crofton, R. W., Diesselhoff-den Dulk, M. M., & van Furth, R. (1978). The origin, kinetics, and characteristics of the Kupffer cells in the normal steady state. J Exp Med, 148(1), 1–17. 70. Nathan, C. F. (1987). Secretory products of macrophages.
J Clin Invest, 79(2), 319–326.
71. Lotzova, E., Savary, C. A., Champlin, R. E. (1993). Genesis of hu- man oncolytic natural killer cells from primitive CD341CD33– bone marrow progenitors. J Immunol, 150(12), 5263–5269. 72. Res, P., Martinez-Caceres, E., Cristina Jaleco, A., et al. (1996).
CD341CD38dim cells in the human thymus can differenti- ate into T, natural killer, and dendritic cells but are distinct from pluripotent stem cells. Blood, 87(12), 5196–5206. 73. Di Santo, J. P., & Vosshenrich, C. A. (2006). Bone marrow
versus thymic pathways of natural killer cell development.
Immunol Rev, 214, 35–46.
74. Sevilla, D. W., Colovai, A. I., Emmons, F. N., et al. (2010). Hemato- gones: a review and update. Leuk Lymphoma, 51(1), 10–19. 75. McKenna, R. W., Washington, L. T., Aquino, D. B., et al. (2001).
Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry. Blood, 98(8), 2498–2507.
76. Haynes, B. F. (1984). The human thymic microenvironment.
Adv Immunol, 36, 87–142.
77. von Boehmer, H., The, H. S., & Kisielow, P. (1989). The thymus selects the useful, neglects the useless and destroys the harm- ful. Immunol Today, 10(2), 57–61.
78. Grossi, C. E., Cadoni, A., Zicca, A., et al. (1982). Large granular lymphocytes in human peripheral blood: ultrastructural and cytochemical characterization of the granules. Blood, 59(2), 277–283.
79. LeBien, T. W., & Tedder, T. F. (2008). B lymphocytes: how they develop and function. Blood, 112(5), 1570–1580.
80. Zhu, J., & Paul, W. E. (2008). CD4 T cells: fates, functions, and faults. Blood, 112(5), 1557–1569.
81. Vignali, D. A., Collison, L. W., & Workman, C. J. (2008). How regulatory T cells work. Nat Rev Immunol, 8(7), 523–532. 82. Rufer, N., Zippelius, A., Batard, P., et al. (2003). Ex vivo char-
acterization of human CD81 T subsets with distinct replica- tive history and partial effector functions. Blood, 102(5), 1779–1787.
83. Vivier, E., Tomasello, E., Baratin, M., et al. (2008). Functions of natural killer cells. Nat Immunol, 9(5), 503–510.